Objective As technology advances, newborn screening will be possible for conditions not screened today. With an expansion of screening, strategies will be needed to support family adaptation to unexpected and possibly uncertain genetic information provided shortly after birth. Method Although candidate conditions for expanded newborn screening will typically be associated with increased morbidity or mortality, for most there is no proven medical treatment that must be implemented quickly. Many will have clinical features that gradually emerge and for which the severity of impact is not predictable. Parents will seek guidance on information, support, and treatment possibilities. This article summarizes issues evoked by expanded newborn scree...
In this article, we discuss the radical uncertainties unleashed by expanded prenatal genetics. We sh...
Newborn screening (NBS) is the largest public health program in the United States, affecting every n...
Newborn screening programs historically sought to identify infants born with inborn errors of metabo...
Objective As technology advances, newborn screening will be possible for conditions not screened tod...
Objective As technology advances, newborn screening will be possible for conditions not screened tod...
With the advent of new genetic technologies and the Human Genome Initiative, interest in the problem...
Genomic advances have contributed to a proliferation of newborn screening (NBS) programs. Psychosoci...
Virtually all 4.25 million babies born annually in the United States are screened for more than 50 r...
The review of the psychosocial effects of newborn genetic susceptibility testing has highlighted the...
Each year, through population-based newborn screening (NBS), 1 in 294 newborns is identified with a ...
Progress in newborn screening (NBS) has been driven for 60 years by developments in science and tech...
Virtually all 4.25 million babies born annually in the United States are screened for more than 50 r...
Since newborn screening (NBS) began in the 1960s, technological advances have enabled its expansion ...
Advances in genomic medicine have lead to considerable debate over the potential for inclusion of ge...
In the US, newborn screening (NBS) is a unique health program that supports health equity and screen...
In this article, we discuss the radical uncertainties unleashed by expanded prenatal genetics. We sh...
Newborn screening (NBS) is the largest public health program in the United States, affecting every n...
Newborn screening programs historically sought to identify infants born with inborn errors of metabo...
Objective As technology advances, newborn screening will be possible for conditions not screened tod...
Objective As technology advances, newborn screening will be possible for conditions not screened tod...
With the advent of new genetic technologies and the Human Genome Initiative, interest in the problem...
Genomic advances have contributed to a proliferation of newborn screening (NBS) programs. Psychosoci...
Virtually all 4.25 million babies born annually in the United States are screened for more than 50 r...
The review of the psychosocial effects of newborn genetic susceptibility testing has highlighted the...
Each year, through population-based newborn screening (NBS), 1 in 294 newborns is identified with a ...
Progress in newborn screening (NBS) has been driven for 60 years by developments in science and tech...
Virtually all 4.25 million babies born annually in the United States are screened for more than 50 r...
Since newborn screening (NBS) began in the 1960s, technological advances have enabled its expansion ...
Advances in genomic medicine have lead to considerable debate over the potential for inclusion of ge...
In the US, newborn screening (NBS) is a unique health program that supports health equity and screen...
In this article, we discuss the radical uncertainties unleashed by expanded prenatal genetics. We sh...
Newborn screening (NBS) is the largest public health program in the United States, affecting every n...
Newborn screening programs historically sought to identify infants born with inborn errors of metabo...